A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
Public ClinicalTrials.gov record NCT03144674. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label, 2-Cohort Study of INCB050465, a PI3Kδ Inhibitor, in Subjects With Relapsed or Refractory Marginal Zone Lymphoma With or Without Prior Exposure to a BTK Inhibitor (CITADEL-204)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and efficacy of two parsaclisib treatment regimens in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton's tyrosine kinase (BTK) inhibitor.
Study identification
- NCT ID
- NCT03144674
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2017 (Actual)
- Primary completion
- Jan 15, 2021 (Actual)
- Completion
- May 29, 2024 (Actual)
- Last update posted
- Jul 11, 2025
2017 – 2024
United States locations
- U.S. sites
- 33
- U.S. states
- 18
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama At Birmingham Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Arizona Oncology Associates | Tempe | Arizona | 85284 | — |
| Torrance Health Association | Redondo Beach | California | 90277 | — |
| Sansum Clinic | Santa Barbara | California | 93105 | — |
| Central Coast Medical Oncology | Santa Maria | California | 93454 | — |
| UCLA Healthcare Hematology-Oncology | Santa Monica | California | 90404 | — |
| St. Joseph Heritage Healthcare | Santa Rosa | California | 95403 | — |
| Innovative Clinical Research Institute | Whittier | California | 90603 | — |
| Loyola University Medical Center | Whittier | California | 90603 | — |
| Valley View Hospital | Glenwood Springs | Colorado | 81601 | — |
| St. Mary'S Hospital Regional Cancer Center | Grand Junction | Colorado | 81501 | — |
| University of Miami Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | — |
| Advanced Pharma Cr | Miami | Florida | 33147 | — |
| Boca Raton Clinical Research Medical Inc. | Plantation | Florida | 33322 | — |
| Asclepes Research Centers | Weeki Wachee | Florida | 34607 | — |
| Robert H. Lurie Comprehensive Cancer Center of Northwestern University | Chicago | Illinois | 60611 | — |
| Rush University Medical Center - Consultants in Hematology | Chicago | Illinois | 60612 | — |
| Clinical Trials of Swla Llc | Lake Charles | Louisiana | 70601 | — |
| University of Michigan Cancer Center | Ann Arbor | Michigan | 48109 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Saint Luke'S Hospital of Kansas City | Kansas City | Missouri | 64111 | — |
| COMPREHENSIVE CANCER CeNTERS OF NEVADA - TWAIN | Las Vegas | Nevada | 89169 | — |
| Clinical Research Alliance | New Hyde Park | New York | 11042 | — |
| Nyu Cancer Institute | New York | New York | 10016 | — |
| Hematology Oncology Associates of Rockland | Nyack | New York | 10960 | — |
| White Plains Hospital | White Plains | New York | 10601 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Gettysburg Cancer Center | Gettysburg | Pennsylvania | 17325 | — |
| Charleston Hematology Oncology Associates Pa | Charleston | South Carolina | 29414 | — |
| Renovatio Clinical | The Woodlands | Texas | 77380 | — |
| University of Washington - Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03144674, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 11, 2025 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03144674 live on ClinicalTrials.gov.